Keyphrases
Interferon-α (IFN-α)
100%
Programmed Death-ligand 1 (PD-L1)
100%
Blast Cells
100%
Acute Myeloid Leukemia
100%
B7-H1 Expression
100%
T Cells
11%
Elderly Patients
11%
Initial Treatment
11%
Treatment Outcome
11%
Conflicting Results
11%
Current Treatment
11%
T Cell Activation
11%
Healthy Donors
11%
Clinical Benefit
11%
Immunotherapeutic Approaches
11%
Precursor Cells
11%
Leukemia Patients
11%
Minor Differences
11%
Stem Cell Transplantation
11%
High Response Rate
11%
Acute Myeloid Leukemia Cells
11%
Frequent Relapses
11%
Dormant
11%
CD274
11%
Leukemia Therapy
11%
B7 Family
11%
B7-H1
11%
Myeloid Precursors
11%
Ineligibility
11%
Adaptive Immune Resistance
11%
Consolidation Phase
11%
CD279
11%
Medicine and Dentistry
Death Receptor
100%
Acute Myeloid Leukemia
100%
Blast Cell
100%
Programmed Death 1 Ligand 1
100%
Interferon
100%
T Cell
28%
Programmed Death 1 Receptor
28%
Receptor
14%
Immunity
14%
Elderly Patient
14%
Precursor
14%
Cell Function
14%
Leukemia Cell
14%
Stem Cell Therapy
14%
Immunology and Microbiology
Interferon Type I
100%
Death Receptor
100%
Myeloid
100%
Blast Cell
100%
Programmed Death 1 Ligand 1
100%
Programmed Death 1 Receptor
25%
T Cell
25%
Leukemia Cell
12%
Cell Function
12%
Immunity
12%
Precursor
12%
Stem Cell Transplantation
12%
Pharmacology, Toxicology and Pharmaceutical Science
Death Receptor
100%
Programmed Death 1 Ligand 1
100%
Acute Myeloid Leukemia
100%
Interferon
100%
Programmed Death 1 Receptor
28%
Receptor
14%